(Q65466148)
Statements
ANNOUNCE 2 (English)
0 references
A Phase 1b (Open-Label)/Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma (English)
0 references
2 March 2016
0 references
December 2019
0 references
310
0 references
16 year
0 references